JP2019508175A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019508175A5 JP2019508175A5 JP2018548751A JP2018548751A JP2019508175A5 JP 2019508175 A5 JP2019508175 A5 JP 2019508175A5 JP 2018548751 A JP2018548751 A JP 2018548751A JP 2018548751 A JP2018548751 A JP 2018548751A JP 2019508175 A5 JP2019508175 A5 JP 2019508175A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- self
- assembling peptide
- pancreatic fistula
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 45
- 208000006809 Pancreatic Fistula Diseases 0.000 claims description 26
- 150000001413 amino acids Chemical class 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 239000000017 hydrogel Substances 0.000 claims description 12
- 101100271190 Plasmodium falciparum (isolate 3D7) ATAT gene Proteins 0.000 claims description 4
- 239000012867 bioactive agent Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 238000001727 in vivo Methods 0.000 claims description 4
- 230000004962 physiological condition Effects 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 101710197241 Accessory gland-specific peptide 70A Proteins 0.000 claims 1
- 238000001338 self-assembly Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662310124P | 2016-03-18 | 2016-03-18 | |
| US62/310,124 | 2016-03-18 | ||
| PCT/IB2017/000366 WO2017158432A1 (en) | 2016-03-18 | 2017-03-17 | Pancreatic fistula occlusion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019508175A JP2019508175A (ja) | 2019-03-28 |
| JP2019508175A5 true JP2019508175A5 (OSRAM) | 2020-04-23 |
Family
ID=58672629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548751A Pending JP2019508175A (ja) | 2016-03-18 | 2017-03-17 | 膵液瘻の閉鎖 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200078489A1 (OSRAM) |
| EP (1) | EP3429646A1 (OSRAM) |
| JP (1) | JP2019508175A (OSRAM) |
| CN (1) | CN109152861A (OSRAM) |
| AU (1) | AU2017235871A1 (OSRAM) |
| BR (1) | BR112018068838A2 (OSRAM) |
| CL (1) | CL2018002644A1 (OSRAM) |
| MX (1) | MX2018011120A (OSRAM) |
| WO (1) | WO2017158432A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190091376A1 (en) | 2016-03-18 | 2019-03-28 | 3-D Matrix, Ltd. | Preventing Biological Tissue Adhesion |
| JP6912953B2 (ja) * | 2016-06-27 | 2021-08-04 | 三洋化成工業株式会社 | 体液漏出防止剤 |
| US20210220429A1 (en) * | 2018-10-05 | 2021-07-22 | Kurume University | Pharmaceutical composition for treating or preventing ulcer or fistula in intestinal tract |
| WO2021171846A1 (ja) * | 2020-02-28 | 2021-09-02 | 株式会社メニコン | 消化液漏出防止材および消化液による消化からの器官保護材 |
| EP4125995A4 (en) | 2020-03-31 | 2024-04-10 | 3-D Matrix, Ltd. | STERILIZATION OF SELF-ASSEMBLY PEPTIDES BY IRRADIATION |
| CN111939323B (zh) * | 2020-08-08 | 2022-06-10 | 武汉速普生物科技有限公司 | 含有透明质酸连接肽和连接蛋白末端肽的功能性多肽水凝胶及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5204646B2 (ja) * | 2005-04-25 | 2013-06-05 | マサチューセッツ インスティテュート オブ テクノロジー | 止血および他の生理学的活性を促進するための組成物および方法 |
| WO2009049022A1 (en) * | 2007-10-10 | 2009-04-16 | Ore Pharmaceuticals Inc. | Method for treatment of pancreatitis |
| US10576123B2 (en) * | 2008-10-06 | 2020-03-03 | 3-D Matrix, Ltd. | Tissue occluding agent comprising an IEIKIEIKIEIKI peptide |
| WO2014141160A1 (en) * | 2013-03-14 | 2014-09-18 | 3-D Matrix, Ltd | Treatment for bile leakage |
| CN105342984A (zh) * | 2014-08-21 | 2016-02-24 | 中国人民解放军总医院 | 一种用于治疗急性胰腺炎的可注射温敏凝胶制剂 |
-
2017
- 2017-03-17 JP JP2018548751A patent/JP2019508175A/ja active Pending
- 2017-03-17 AU AU2017235871A patent/AU2017235871A1/en not_active Abandoned
- 2017-03-17 CN CN201780030462.XA patent/CN109152861A/zh active Pending
- 2017-03-17 US US16/085,804 patent/US20200078489A1/en not_active Abandoned
- 2017-03-17 BR BR112018068838A patent/BR112018068838A2/pt not_active Application Discontinuation
- 2017-03-17 MX MX2018011120A patent/MX2018011120A/es unknown
- 2017-03-17 EP EP17722145.4A patent/EP3429646A1/en not_active Withdrawn
- 2017-03-17 WO PCT/IB2017/000366 patent/WO2017158432A1/en not_active Ceased
-
2018
- 2018-09-14 CL CL2018002644A patent/CL2018002644A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019508175A5 (OSRAM) | ||
| Patrulea et al. | An update on antimicrobial peptides (AMPs) and their delivery strategies for wound infections | |
| Ibraheem et al. | Administration strategies for proteins and peptides | |
| JP6084655B2 (ja) | 病原体に対する哺乳類先天性免疫抵抗性の刺激のための組成物 | |
| JP2019533722A5 (OSRAM) | ||
| JP2011502479A5 (OSRAM) | ||
| JP6158713B2 (ja) | ヒトラクトフェリン由来ペプチド及びその使用 | |
| JP2014508734A5 (OSRAM) | ||
| JPWO2019156137A5 (OSRAM) | ||
| US11603394B2 (en) | Targeted effector proteins and uses thereof | |
| EP3768295A1 (en) | Sap and peptidomimetic compositions for reducing symptoms of inflammation | |
| RU2016152151A (ru) | Препарат, содержащий фактор viii и пептиды фактора фон виллебранда | |
| DK1427436T3 (da) | Anvendelse af mælkeserumapoproteiner til profylakse eller behandling af mikrobiel eller viral infektion | |
| JP2016520620A5 (OSRAM) | ||
| JP6211169B2 (ja) | マイクロニードル | |
| Beaumont et al. | LL-37: an immunomodulatory antimicrobial host defence peptide | |
| WO2017158432A1 (en) | Pancreatic fistula occlusion | |
| US20220226499A1 (en) | Metabolite Delivery for Modulating Metabolic Pathways of Cells | |
| RU2011133224A (ru) | Новые фармацевтические композиции | |
| JP2019508181A5 (OSRAM) | ||
| JP2019508184A5 (OSRAM) | ||
| EA202090802A1 (ru) | Пептидная композиция для лечения повреждений, связанных с возбуждающей нейротоксичностью | |
| Yadav et al. | Nano-enhanced peptides: bridging cutting-edge tech and biology to outsmart resilient microbes | |
| US20240226809A9 (en) | Methods of isolating exosomes | |
| JP2015505551A5 (OSRAM) |